MXPA05003881A - Preparacion de compuestos triazospiro. - Google Patents

Preparacion de compuestos triazospiro.

Info

Publication number
MXPA05003881A
MXPA05003881A MXPA05003881A MXPA05003881A MXPA05003881A MX PA05003881 A MXPA05003881 A MX PA05003881A MX PA05003881 A MXPA05003881 A MX PA05003881A MX PA05003881 A MXPA05003881 A MX PA05003881A MX PA05003881 A MXPA05003881 A MX PA05003881A
Authority
MX
Mexico
Prior art keywords
preparation
triazospiro
compounds
triazospiro compounds
processes
Prior art date
Application number
MXPA05003881A
Other languages
English (en)
Inventor
R Goehring Richard
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of MXPA05003881A publication Critical patent/MXPA05003881A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Abstract

La presente invencion se refiere a un proceso para producir compuestos triazospiro que tienen la formula (IV); en donde A, B, C, R, R1 y W son como se definen en este documento.
MXPA05003881A 2002-10-17 2003-10-16 Preparacion de compuestos triazospiro. MXPA05003881A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41930502P 2002-10-17 2002-10-17
US41960002P 2002-10-18 2002-10-18
PCT/US2003/032591 WO2004034983A2 (en) 2002-10-17 2003-10-16 Preparation of triazospiro compounds

Publications (1)

Publication Number Publication Date
MXPA05003881A true MXPA05003881A (es) 2005-10-05

Family

ID=32110232

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05003881A MXPA05003881A (es) 2002-10-17 2003-10-16 Preparacion de compuestos triazospiro.

Country Status (8)

Country Link
US (1) US20110092704A1 (es)
EP (1) EP1551400A2 (es)
JP (1) JP2006503093A (es)
AU (1) AU2003279276A1 (es)
CA (1) CA2501798A1 (es)
HR (1) HRP20050442A2 (es)
MX (1) MXPA05003881A (es)
WO (1) WO2004034983A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102105465B (zh) 2008-07-21 2015-03-11 普渡制药公司 取代的喹喔啉型桥连哌啶化合物及其用途
WO2014102589A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Quinazolin-4(3h)-one-type piperidine compounds and uses thereof
US9963458B2 (en) 2012-12-27 2018-05-08 Purdue Pharma L.P. Indole and indoline-type piperidine compounds and uses thereof
WO2014102590A1 (en) 2012-12-27 2014-07-03 Purdue Pharma L.P. Substituted piperidin-4-amino-type compounds and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0401333A3 (en) * 2001-04-18 2004-11-29 Euro Celtique Sa Spiropyrazole compounds and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2004034983A3 (en) 2004-07-22
AU2003279276A1 (en) 2004-05-04
HRP20050442A2 (en) 2005-12-31
CA2501798A1 (en) 2004-04-29
JP2006503093A (ja) 2006-01-26
WO2004034983A2 (en) 2004-04-29
US20110092704A1 (en) 2011-04-21
EP1551400A2 (en) 2005-07-13

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03009604A (es) Compuestos de espiropirazol.
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
WO2004048380A8 (en) Process for the synthesis of ganciclovir
MXPA05003881A (es) Preparacion de compuestos triazospiro.
MXPA03006866A (es) Modificacion cristalina de depsipeptido ciclico con actividad mejorada.
SG146645A1 (en) Process for the synthesis of 6-amino-4-(3-chloro-4fluoro-phenylamino)-7- ethoxy-quinoline-3-carbonitrile
WO2005054175A3 (en) New process for the preparation of nitrooxyderivatives of paracetamol
MX2009013336A (es) Sintesis de 3-aminopirazoles sustituidos.
MXPA05013649A (es) Fluorbutenos nematicidas que contienen tiazolina.
CA2425368A1 (en) New sulphoxybenzamides
MXPA04000623A (es) Derivados de tetrahidropiridazina y su uso como pesticidas.
HU0201195D0 (es)
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
TW200420552A (en) Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture
GB0314299D0 (en) Chemical compounds
TW200420553A (en) Process for the synthesis of 3, 3a, 6, 6a-tetrahydro-2H-cyclopentan[b]furan-2-one
MXPA04001851A (es) Inda-1-onas c2-disustituidas y sus derivados, metodo para su produccion y su uso como medicamentos.